
Louise Wang Zhiying Humphrey
Examiner (ID: 17515)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 628 |
| Issued Applications | 269 |
| Pending Applications | 52 |
| Abandoned Applications | 313 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5010477
[patent_doc_number] => 20070280956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Novel hepatitis C virus peptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/708175
[patent_app_country] => US
[patent_app_date] => 2007-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16223
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280956.pdf
[firstpage_image] =>[orig_patent_app_number] => 11708175
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/708175 | Alternate reading frame hepatitis C virus peptides and uses thereof | Feb 19, 2007 | Issued |
Array
(
[id] => 5253263
[patent_doc_number] => 20070134719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Method of controlling pharmacokinetics of immunomodulatory compounds'
[patent_app_type] => utility
[patent_app_number] => 11/704574
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8432
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134719.pdf
[firstpage_image] =>[orig_patent_app_number] => 11704574
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/704574 | Method of controlling pharmacokinetics of immunomodulatory compounds | Feb 8, 2007 | Abandoned |
Array
(
[id] => 4669750
[patent_doc_number] => 20080044810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS'
[patent_app_type] => utility
[patent_app_number] => 11/704898
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 44326
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044810.pdf
[firstpage_image] =>[orig_patent_app_number] => 11704898
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/704898 | Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Feb 7, 2007 | Abandoned |
Array
(
[id] => 4657146
[patent_doc_number] => 20080026007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Potentiation of the immune response'
[patent_app_type] => utility
[patent_app_number] => 11/703058
[patent_app_country] => US
[patent_app_date] => 2007-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3336
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026007.pdf
[firstpage_image] =>[orig_patent_app_number] => 11703058
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/703058 | Potentiation of the immune response | Feb 5, 2007 | Abandoned |
Array
(
[id] => 6577319
[patent_doc_number] => 20100047275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'PEPTIDE SEQUENCES AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/278728
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 33264
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047275.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278728
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278728 | Peptide sequences and compositions | Feb 4, 2007 | Issued |
Array
(
[id] => 5446435
[patent_doc_number] => 20090047661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'QUANTITATIVE HIV PHENOTYPE OR TROPISM ASSAY'
[patent_app_type] => utility
[patent_app_number] => 12/159813
[patent_app_country] => US
[patent_app_date] => 2007-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5813
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047661.pdf
[firstpage_image] =>[orig_patent_app_number] => 12159813
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/159813 | Quantitative HIV phenotype or tropism assay | Feb 1, 2007 | Issued |
Array
(
[id] => 4826818
[patent_doc_number] => 20080125362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Method of screening compound preventing cells from infection with Hepatitis C virus (HCV)'
[patent_app_type] => utility
[patent_app_number] => 11/699578
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 24277
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125362.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699578
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699578 | Method of screening compound preventing cells from infection with Hepatitis C virus (HCV) | Jan 29, 2007 | Abandoned |
Array
(
[id] => 4682305
[patent_doc_number] => 20080248531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Preparation of fully human antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/699822
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9718
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248531.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699822
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699822 | Preparation of fully human antibodies | Jan 28, 2007 | Abandoned |
Array
(
[id] => 4657210
[patent_doc_number] => 20080026071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Microparticles for delivery of heterologous nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 11/653792
[patent_app_country] => US
[patent_app_date] => 2007-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29423
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026071.pdf
[firstpage_image] =>[orig_patent_app_number] => 11653792
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/653792 | Microparticles for delivery of heterologous nucleic acids | Jan 15, 2007 | Abandoned |
Array
(
[id] => 5236064
[patent_doc_number] => 20070128221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Hepatitis-C virus testing'
[patent_app_type] => utility
[patent_app_number] => 11/652862
[patent_app_country] => US
[patent_app_date] => 2007-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 17846
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128221.pdf
[firstpage_image] =>[orig_patent_app_number] => 11652862
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/652862 | Hepatitis-C virus testing | Jan 11, 2007 | Issued |
Array
(
[id] => 5501695
[patent_doc_number] => 20090162383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Method for designing vaccines against constantly mutating pathogens'
[patent_app_type] => utility
[patent_app_number] => 11/645448
[patent_app_country] => US
[patent_app_date] => 2006-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9252
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162383.pdf
[firstpage_image] =>[orig_patent_app_number] => 11645448
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/645448 | Method for designing vaccines against constantly mutating pathogens | Dec 25, 2006 | Abandoned |
Array
(
[id] => 9166484
[patent_doc_number] => 08592161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance'
[patent_app_type] => utility
[patent_app_number] => 11/613584
[patent_app_country] => US
[patent_app_date] => 2006-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6681
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11613584
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/613584 | Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance | Dec 19, 2006 | Issued |
Array
(
[id] => 5367669
[patent_doc_number] => 20090305228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Potentiation of Apoptosis by Monoclonal Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/097686
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4759
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305228.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097686
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097686 | Potentiation of Apoptosis by Monoclonal Antibodies | Dec 14, 2006 | Abandoned |
Array
(
[id] => 5177528
[patent_doc_number] => 20070178588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Tissue control rods for sheet-based tissue engineering'
[patent_app_type] => utility
[patent_app_number] => 11/640470
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14489
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178588.pdf
[firstpage_image] =>[orig_patent_app_number] => 11640470
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/640470 | Tissue control rods for sheet-based tissue engineering | Dec 13, 2006 | Abandoned |
Array
(
[id] => 5189523
[patent_doc_number] => 20070167832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Analysis of Gases'
[patent_app_type] => utility
[patent_app_number] => 11/566919
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7534
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167832.pdf
[firstpage_image] =>[orig_patent_app_number] => 11566919
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/566919 | Analysis of gases | Dec 4, 2006 | Issued |
Array
(
[id] => 6530526
[patent_doc_number] => 20100221242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'ANTI-VIRAL GRIFFITHSIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/095697
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29108
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221242.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095697
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095697 | Anti-viral griffithsin compounds, compositions and methods of use | Nov 30, 2006 | Issued |
Array
(
[id] => 5135628
[patent_doc_number] => 20070077257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications'
[patent_app_type] => utility
[patent_app_number] => 11/604553
[patent_app_country] => US
[patent_app_date] => 2006-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 177
[patent_figures_cnt] => 177
[patent_no_of_words] => 40459
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077257.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604553 | Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications | Nov 26, 2006 | Abandoned |
Array
(
[id] => 4954530
[patent_doc_number] => 20080187554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Process for producing stable HIV Th-CTL peptides'
[patent_app_type] => utility
[patent_app_number] => 11/592404
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 3941
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187554.pdf
[firstpage_image] =>[orig_patent_app_number] => 11592404
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/592404 | Process for producing stable HIV Th-CTL peptides | Nov 2, 2006 | Abandoned |
Array
(
[id] => 4443890
[patent_doc_number] => 07862820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Immunoglobulin chimeric monomer-dimer hybrids'
[patent_app_type] => utility
[patent_app_number] => 11/588431
[patent_app_country] => US
[patent_app_date] => 2006-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 40
[patent_no_of_words] => 36924
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/862/07862820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11588431
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/588431 | Immunoglobulin chimeric monomer-dimer hybrids | Oct 26, 2006 | Issued |
Array
(
[id] => 5219670
[patent_doc_number] => 20070160981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'VIRAL PROTEASE'
[patent_app_type] => utility
[patent_app_number] => 11/551789
[patent_app_country] => US
[patent_app_date] => 2006-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12507
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160981.pdf
[firstpage_image] =>[orig_patent_app_number] => 11551789
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/551789 | VIRAL PROTEASE | Oct 22, 2006 | Abandoned |